...We Welcome You To The Resverlogix HUB withIn The AGORACOM COMMUNITY!

Free
Message: Revised target market, indications, market potential? ... and some numbers?

good point....why would a partner sign-up, only to have RVX try it on with another pharma with a different compound.  Yes, some sort of exclusivity clause makes sense.  I guess I'll have to try some other angle to find some leverage.

Share
New Message
Please login to post a reply